Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive versus conventional insulin therapy in severely burned patients
ChiCTR-TRC-12001906Phase 4Completed
- Sponsor
- Fourth Medical Center of PLA General Hospital
- Start
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of human insulin in burn injury (2 arms), sponsored by Fourth Medical Center of PLA General Hospital. Primary endpoints: 28-day mortality, 60-day mortality and 3 more. Started Dec 2011; status: completed.
02
Drugs
human insulin
03
Conditions
burn injury
Beyond the preview
Go deeper on ChiCTR-TRC-12001906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12001906.